Drug Approval | July 02, 2022
Ascentage Pharma gets IND clearance by the US FDA for novel EED Inhibitor APG-5918
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
Earlier initiation with Kesimpta resulted in a more than three-fold increased likelihood of maintaining NEDA-3 throughout the study
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
The Congress was held on June, 20-21, 2022 in Berlin, Germany
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.
63-year old woman gets rare Transcatheter Tricuspid Valve Replacement (TTVR)
Subscribe To Our Newsletter & Stay Updated
